Ekrem Tok Mental Health Hospital, Adana, Turkey.
Eur Rev Med Pharmacol Sci. 2012 Oct;16 Suppl 4:70-3.
Despite its serious side effects, clozapine is still the golden standard in treatment of schizophrenia due to its effectiveness and lack of extrapyramidal side effects. Some studies have mentioned withdrawal symptoms, including withdrawal psychosis after stopping clozapine, and have tried to explain this severe symptom through dopamine receptor supersensitivity. This phenomenon, called supersensitivity psychosis, can be explained by the development of tolerance towards the effect of the medication. In literature, there are several cases of supersensitivity psychosis while using other neuroleptics. However, to our knowledge, there are no published cases reporting an association between clozapine and supersensitivity psychosis. The current patient, who has been diagnosed as resistant schizophrenia, responded well to the clozapine in the beginning of treatment. Due to an effective dose of clozapine, he had psychotic exacerbation with significant positive symptoms. We discuss the probable reasons causing this situation and the relationship between tolerance to the treatment effect and the dopamine supersensitivity.
尽管氯氮平有严重的副作用,但由于其疗效确切且无锥体外系副作用,它仍是治疗精神分裂症的金标准。一些研究提到了停药症状,包括停用氯氮平后的停药精神病,并且试图通过多巴胺受体超敏性来解释这种严重的症状。这种现象称为超敏性精神病,可以通过对药物作用的耐受性发展来解释。在文献中,有几种使用其他神经阻滞剂发生超敏性精神病的情况。但是,据我们所知,尚无关于氯氮平与超敏性精神病之间关联的报道。目前的患者被诊断为难治性精神分裂症,在开始治疗时对氯氮平反应良好。由于氯氮平的有效剂量,他出现了明显阳性症状的精神病恶化。我们讨论了导致这种情况的可能原因以及治疗效果的耐受性与多巴胺超敏性之间的关系。